Unichem to Consolidate US Formulation Business | Latest News
Unichem Laboratories to consolidate its US formulation business under one entity. The board will meet on September 30th to consider the integration of Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals Inc.
New Delhi, Sep 23 (PTI) Drug firm Unichem Laboratories on Monday said its board will meet next week to consider consolidation of its US formulation business under one entity.
The board, on September 30, will consider integration and consolidation of the generics formulations business in the US market of Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals Inc, it said in a regulatory filing.
The initiative is to consolidate all the Ipca Group's US generics formulations business under one entity, it added.
Shares of Unichem Laboratories were trading 2.59 per cent down at Rs 628.05 apiece on the BSE.
The board, on September 30, will consider integration and consolidation of the generics formulations business in the US market of Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals Inc, it said in a regulatory filing.
The initiative is to consolidate all the Ipca Group's US generics formulations business under one entity, it added.
Shares of Unichem Laboratories were trading 2.59 per cent down at Rs 628.05 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.26 ( -2.55)
- 56849105
- Pro Fin Capital Serv
- 4.71 ( -4.85)
- 18863071
- Srestha Finvest
- 0.55 ( -3.51)
- 18602596
- G G Engineering
- 0.99 ( -1.00)
- 14282764
- Guj. Toolroom Lt
- 1.66 (+ 4.40)
- 13499062
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback